CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 103 filers reported holding CYTOSORBENTS CORP in Q2 2021. The put-call ratio across all filers is 2.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $27,000 | -52.6% | 12,531 | -29.8% | 0.00% | – |
| Q1 2022 | $57,000 | -21.9% | 17,858 | +84.4% | 0.00% | -100.0% |
| Q2 2021 | $73,000 | -33.6% | 9,682 | -23.8% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | -63.3% | 12,701 | -66.2% | 0.00% | -75.0% |
| Q4 2020 | $300,000 | -62.4% | 37,610 | -62.4% | 0.00% | -66.7% |
| Q3 2020 | $798,000 | +26.1% | 100,095 | +56.6% | 0.01% | +9.1% |
| Q2 2020 | $633,000 | – | 63,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |